(Q53079458)

English

Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.

scientific article published on 18 December 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

1 reference

based on heuristic

inferred from title

Josep Castellvi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Santiago Montes-Moreno

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Miguel A. Piris

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Juan-Manuel Sancho

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

10

object named as

Ana Batlle

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

object named as

Noelia Purroy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sonia Gonzalez de Villambrosia

11

object named as

Sonia Gonzalez de Villambrosia

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Juan Bergua

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Laura Gallur

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Julio Prieto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Luis A Lopez

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Jose A García-Marco

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Fernando Carnicero

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Lucía Ferrando-Lamana

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Andrés Lopez

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

0 references

publication date

18 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

169

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

188-198

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25521006%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Genetic immunization: a new monoclonal antibody for the detection of BCL-6 protein in paraffin sections

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Tissue microarray technology for high-throughput molecular profiling of cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13273

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53079458&oldid=2231184414"